Diabetic Retinopathy and Peripapillary Retinal Thickness by Cho, Hee Yoon et al.
16
Korean J Ophthalmol 2010;24(1):16-22
DOI: 10.3341/kjo.2010.24.1.16 pISSN: 1011-8942 eISSN: 2092-9382
Original Article
Diabetic Retinopathy and Peripapillary Retinal Thickness
Hee Yoon Cho
1, Dong Hoon Lee
2, Song Ee Chung
2, Se Woong Kang
2
1Department of Ophthalmology, Hanyang University College of Medicine, Seoul, Korea
2Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Purpose: To assess the diagnostic efficacy of macular and peripapillary retinal thickness measurements for the 
staging of diabetic retinopathy (DR) and the prediction of disease progression. 
Methods: In this prospective study, 149 diabetic patients (149 eyes) and 50 non-diabetic control subjects were 
included. Baseline optical coherence tomography was employed to measure retinal thickness in the macula 
(horizontal, vertical, and central) and the peripapillary zone (superior, inferior, nasal, and concentric to the optic 
disc). Seven baseline parameters were correlated with the DR stages identified by fluorescein angiography. 
Baseline retinal thickness was compared between groups of patients requiring panretinal photocoagulation 
(PRP) within 6 months (PRP group) and patients not requiring PRP (No-PRP group).
Results: Macular and peripapillary retinal thicknesses in diabetic subjects were significantly greater than that in 
normal controls (p<0.05). All retinal thickness parameters, and particularly peripapillary circular scans, tended to 
increase with increasing DR severity (p<0.05). The baseline thicknesses of the peripapillary circular scans were 
greater in the PRP group than in the no-PRP group (p<0.05). 
Conclusions: Peripapillary retinal thickness may prove to be a useful criterion for DR severity and may also serve as 
an indicator of disease progression.
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A principal pathogenic mechanism in diabetic retinopathy 
(DR) is the compromise of the blood-retinal barrier (BRB), 
leading to retinal edema. Subsequent increases in retinal vol-
ume and retinal thickness are relevant quantitative parameters 
for BRB damage [1].
Traditional methods for evaluating macular thickening, 
including slit lamp biomicroscopy and stereo fundus pho-
tography, are relatively insensitive to small alterations in 
retinal thickness [2]. Although fluorescein angiography is 
highly sensitive for the qualitative detection of fluid leak-
age, the technique provides no quantitative measure of ei-
ther BRB alteration or retinal thickening  [3]. Optical coher-
ence tomography (OCT), a non-invasive imaging technol-
ogy that can generate micrometer resolution cross-sectional 
imaging of intraocular structures in a few minutes, allows 
for a quantitative measurement of alterations in retinal 
thickness with good reproducibility [4-6]. 
Given the increasing diabetic population, a cost-effective 
and reliable screening program for DR is essential [7-10]. 
However, interobserver agreement is merely fair for DR 
grading using fundus photography [11,  12]. Interobserver 
agreement is even worse for proliferative diabetic retinop-
athy (PDR), for which diagnostic accuracy is even more 
important [13]. 
In this study, we employed easy-to-use and -reproduce 
OCT to compare the retinal thicknesses of the macula and 
the peripapillary zone in order to determine the relation-
ship between retinal thickness and DR severity. We also 
evaluated the validity of baseline retinal thickness for pre-
dicting disease progression in DR patients. In particular, 
we studied which retinal location was best for evaluating 
the severity of DR and for predicting possible disease 
progression.
Materials and Methods
This study was a prospective observational case series, 
with a study group of type II diabetic patients with or with-HY Cho, et al. Diabetic Retinopathy and PeripapillaryThickness
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Fig.  1. Optic coherence tomography scans were performed at the 
macula and peripapillary zones, indicated by the line superimposed 
on the fundus photograph. Horizontal (H) and vertical (V) scans of 
the macula were centered through the fovea. Superior (S), inferior 
(I) and nasal (N) scans of the peripapillary zone originated within 
the one-third of disc diameter from the disc margin. All linear scans 
were 6 mm in length. The peripapillary circular scan (D) was ob-
tained concentric to the optic disc, with a diameter of 6 mm. 
out DR and a control group of non-diabetic normal subjects. 
We evaluated the subjects seen in our department from August 
2004 to July 2006.
Approval for the use of human subjects was obtained 
from the Institutional Review Board of the Samsung Medical 
Center. All participants provided informed consent prior to 
their participation in the study. 
All of the subjects underwent complete ophthalmologic 
examinations, which included a best-corrected visual acuity 
measurement with the Snellen visual acuity chart, slit-lamp 
biomicroscopy, dilated fundus examinations using a 90-diopter 
pan-fundus lens, and fluorescein angiography. On the basis 
of fundoscopy and angiography, the eyes of the diabetic 
subjects were classified as no DR, mild/moderate/severe 
non-proliferative diabetic retinopathy (NPDR), and PDR [13].
Diabetics with DR should exhibit DR of any stage in at 
least one eye. If both eyes were the same stage, the right 
eye was selected. If eyes demonstrated different stages of 
DR, the eye with the more advanced stage was included. 
The exclusion criteria included preretinal/vitreous hem-
orrhage, advanced cataracts, significant corneal opacities, 
and traction affecting the macular or peripapillary zone. 
Patients having undergone intravitreal injections, laser pho-
tocoagulation (focal or panretinal), or intraocular surgery 
other than cataract extraction conducted more than 6 
months before were also excluded, as these interventions 
may cause retinal thickness changes. Finally, the patients 
had no other retinal diseases, including macular degener-
ation, retinal vein occlusion, or hypertensive retinopathy. 
A single ophthalmic photographer blinded to the sub-
jects’ conditions conducted OCT (Stratus
TM, Carl Zeiss, 
Dublin, CA, USA) scanning in all eyes following pupillarg 
dilation. The macula was initially scanned along the hori-
zontal and vertical meridians using a standard, linear 
cross-hair pattern, with a scan length of 6 mm centered 
through the fovea. In cases in which macular edema pre-
cluded adequate foveal localization of the scan, the OCT 
was centered on the patient’s fixation. For the peripapillary 
zone, three linear scans and one circular scan were conducted 
while a nasally- positioned fixation target was presented to 
the subject. The three peripapillary linear scans included 
one horizontal scan (nasal to optic disc) and two vertical 
scans taken superior and inferior to the optic disc, with a 
scan length of 6 mm starting from within one third of the 
disc diameter from the disc margin in each, in an effort to 
avoid including peripapillary atrophy within the scanned 
zone. The peripapillary circular scan was obtained concen-
tric to the optic disc, resulting in a peripapillary ring of 6 
mm in diameter along the margin of the optic disc.
The OCT parameters of this study, or the calculated 
mean thicknesses of the obtained scans, were abbreviated 
as horizontal (H) and vertical (V) in the macula, and superi-
or (S), inferior (I), nasal (N), and circular along the margin 
of the optic disc (D) in the peripapillary zone, as shown 
in Fig. 1. 
In addition, central macular thickness (CMT) at the deepest 
portion of the foveal pit was determined using manually- 
positioned OCT software-controlled cursors. For all cross- 
sectional OCT scans, retinal thickness was defined as the 
distance between the internal limiting membrane and the 
retinal pigment epithelium, as was determined automatically 
by the OCT analysis software. The mean retinal thickness 
in each location for the six scans was calculated using image 
processing software (Image/J, National Institutes of Health, 
Bethesda, MD, USA). Each individual scan was reviewed 
by a blinded observer (DHL) for aberrant placement of the 
inner and outer retinal borders. If a portion of the thick-
ness measurements were determined to be incorrect, man-
ual correction was applied using image processing soft-
ware to adjust the inner and outer bands. 
At every follow-up visit after the initial examination, bi-
omicroscopic fundus examinations were conducted by one 
examiner (SWK), who was blinded to the patients` eligibility. 
Additionally, when indicated, panretinal photocoagulation (PRP) 
was also conducted during the follow-up period. PRP was 
considered in accordance with the recommendations of the 
Diabetic Retinopathy Study [14]. In patients presenting 
with clinically significant macular edema, macular focal 
laser photocoagulation was administered in accordance 
with the guidelines established in the Early Treatment of 
Diabetic Retinopathy Study [15,  16].
 Eyes with DR were, thus, classified into two groups, 
designated the PRP and No-PRP groups. The PRP group 
included eyes which had required PRP during the 6-month 
follow-up period after the baseline examination, and the 
No-PRP group included eyes which had not required PRP. Korean J Ophthalmol Vol.24, No.1, 2010
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Fig. 2. Retinal thickness (µm) in the normal population, diabetic pa-
tients without retinopathy, and four groups of diabetic patient with 
retinopathy.
DM=diabetes; DR=diabetic retinopathy; NPDR=non-proliferative
diabetic retinopathy; PDR=proliferative diabetic retinopathy; H= 
horizontal in macula; V=vertical in macula; S=superior to optic
disc; I=inferior to optic disc; N=nasal to optic disc; D=circular 
concentric to optic disc; CMT=central macular thickness at foveal pit.
Table 1. Characteristics of diabetic patients and normal subjects
Diabetes with retinopathy 
(N=129)
Diabetes without 
retinopathy (N=20)
Normal population
(N=50)
p-value
*
Age (yr) 62.3±7.3 60.3±9.7 59.3±10.8 NS
*
Sex (M/F) 75/64 9/11 28/22 NS
†
Refractive error (D) -0.1±0.3 -0.4±0.7 -0.3±0.8 NS
*
Values for the diabetic patients and the controls are presented as mean±SD. 
D=diopter; NS=not significant.    
*Kruskal-Wallis test; 
†Chi-square test.
Table 2. Retinal thickness (µm) in the normal population, diabetic patients without retinopathy and four groups of diabetic 
patients with retinopathy
Normal population
(N=50)
Diabetes without DR
(N=20)
Mild NPDR
(N=20)
Moderate NPDR
(N=38)
Severe NPDR
(N=50)
PDR
(N=21)
p-value
*
H 219.2±16.0 207.9±17.8 205.4±17.5 225.3±32.5 251.2±46.8 266.1±77.3 <0.001
V 220.1±18.8 209.3±19.3 206.6±15.3 224.4±36.7 246.5±41.3 258.0±63.2 <0.001
S 192.5±21.1 185.6±13.4 193.6±17.9 200.7±18.4 216.0±22.9 222.5±33.1 <0.001
I 197.2±17.9 195.4±16.3 201.5±15.2 197.0±23.2 219.0±22.3 228.5±55.7 <0.001
N 171.0±22.5 171.3±13.6 162.0±17.6 180.5±22.0 203.6±39.8 202.0±55.0 <0.001
D 203.3±14.4 192.4±15.1 192.5±17.4 200.3±14.8 217.1±26.9 227.7±44.2 <0.001
CMT 141.5±15.3 149.8±14.7 146.9±18.6 182.5±69.8 193.6±77.4   232.1±148.6 <0.001
Mean±SD of retinal thickness is presented in microns.
DR=diabetic retinopathy; NPDR=non-proliferative diabetic retinopathy; PDR=proliferative diabetic retinopathy; H=horizontal in macula; 
V=vertical in macula; S=superior to optic disc; I=inferior to optic disc; N=nasal to optic disc; D=circular concentric to optic disc; CMT 
=central macular thickness at foveal pit.
*Kruskal-Wallis test or ANOVA.
Differences between the two groups in the parameters at 
baseline OCT were evaluated.
All seven of the OCT parameters were then compared 
among the control and diabetic subjects. Correlation analy-
sis was also applied in order to characterize on a loga-
rithmic scale the relationship between the OCT parameters 
and the best-corrected visual acuity.
The efficacy of the OCT parameters as index variables 
for the discrimination of DR stage and as a predictive var-
iable for discrimination between eyes with and without 
PRP within 6 months of baseline OCTs was determined 
via receiver operating characteristic (ROC) analysis. The 
area under the ROC curve (AUC) was calculated for each 
OCT parameter. The best model, as defined by the largest 
AUC and cutoff value characterized by the best trade-off 
between sensitivity and specificity, was determined. The 
statistical calculations were conducted using a SPSS ver. 
11.5 (SPSS Inc., Chicago, IL, USA). The p-values of less 
than 0.05 were considered significant.
Results
A total of 129 consecutive diabetics with DR (129 eyes) 
and 20 diabetics without DR (20 eyes) were enrolled in 
this study. The control group consisted of 50 non-diabetic, 
age- and sex-matched normal subjects (50 eyes). 
The clinical characteristics of the three groups are sum-
marized in Table 1. The mean age, gender ratio, and re-
fractive errors did not differ among the three groups. 
Based on the initial fundus examinations and fluorescein 
angiography, the 129 diabetics with DR were classified as HY Cho, et al. Diabetic Retinopathy and PeripapillaryThickness
19
Table 3. Point estimates and standard errors for area under the ROC curves of optic coherence tomography parame-
ters for discriminating between mild/moderate non-proliferative diabetic retinopathy (NPDR) and severe NPDR/PDR 
AUC SE 95% CI for AUC p-value
*
D 0.76 0.043 0.65,  0.82 <0.001
N 0.75 0.043 0.65,  0.82 <0.001
I 0.74 0.043 0.64,  0.82 <0.001
V 0.74 0.044 0.64,  0.81 <0.001
H 0.74 0.044 0.64,  0.81 <0.001
S 0.71 0.045 0.61,  0.79 <0.001
CMT 0.59  0.050 0.47, 0.67    0.068
ROC=receiver operating characteristic; AUC=area under the ROC curves; SE=standard errors; D=circular concentric to optic disc; 
N=nasal to optic disc; I=inferior to optic disc; V=vertical in macula; H=horizontal in macula; S=superior to optic disc; CMT=central 
macular thickness at fovea pit. 
*Significance of the null hypothesis that the true AUC is 0.5.
Table 4. Point estimates and standard errors for area under the ROC curves of optic coherence tomography 
parameters for discriminating between panretinal photocoagulation (PRP, 26 eyes) and No-PRP group (45 eyes)
AUC SE 95% CI for AUC  p-value
*
D 0.62 0.071 0.54, 0.82  0.047 
CMT 0.57 0.075  0.52,  0.80  0.340 
V 0.55 0.075  0.49,  0.76  0.449 
N 0.53 0.074 0.46,  0.76 0.646 
H 0.52 0.074 0.46,  0.75 0.738 
S 0.52 0.075  0.44,  0.73  0.835 
I 0.50 0.074  0.44,  0.73  0.962 
Subsequent panretinal photocoagulation had been conducted for the panretinal photocoagulation group within the 6-mon follow-up period after 
baseline optic coherence tomography measurements.
ROC=receiver operating characteristic; AUC=area under the ROC curves; SE=standard errors; D=circular concentric to optic disc; 
CMT=central macular thickness at fovea pit; V=vertical in macula; N=nasal to optic disc; H=horizontal in macula; S=superior to optic disc; 
I=inferior to optic disc.
*Significance of the null hypothesis that the true AUC is 0.5.
follows: mild NPDR (20 eyes, 15.5%), moderate NPDR 
(38 eyes, 29.5%), severe NPDR (50 eyes, 38.8%), and PDR 
(21 eyes, 16.2%). 
The evaluation of retinal thicknesses according to the 
severity of DR is summarized in Table 2. We noted stat-
istically significant differences in retinal thickness in each 
of the scans between diabetic and normal subjects. In the 
post hoc test of multiple comparison, the difference in 
thickness among subjects with mild NPDR and normal 
control subjects was significant only in the S and D scans 
in the peripapillary area (Kruskal-Wallis test, p=0.012, 
0.042). The differences between subjects with mild NPDR 
and diabetics without DR, and between diabetics without 
DR and normal control subjects, were not significant in all 
scans. The mean thickness tended to increase with the se-
verity of DR (Fig. 2), but only part of the comparison was 
statistically significant in multiple comparisons with post- 
hoc tests (mild NPDR<moderate NPDR<severe NPDR/ PDR 
with  p<0.03 in the H, N scan and mild NPDR/moderate 
NPDR<severe NPDR/PDR with p<0.01 in the V, S, I, D scan).
CMT values were minimal among all measured thick-
nesses in all stages of DR except for PDR (Friedman Test, 
p<0.001). The retinal thickness upon OCT scan in the 
macula (H, V scan) was greater than that in the peripapil-
lary zone (S, I, N, D scan) (p<0.001). The coefficient of 
variance in thickness tended to be greater in eyes with 
more advanced DR. CMT found the largest coefficient of 
variance of all DR stages.
The H, V and D scans demonstrated negative correla-
tions with age, and the H scan was most closely correlated 
with age (spearman r=0.269, p<0.001). When the OCT pa-
rameters were plotted against the logMAR visual acuities 
in all study groups, with the exception of the I scan in the 
peripapillary area, there were significant correlations be-
tween retinal thickness and visual acuity. CMT showed the 
strongest correlation among all OCT measurements 
(r=0.349,  p<0.001). 
Table 3 shows the AUC values for each of seven retinal 
thickness measurements for discrimination between early 
stage (mild and moderate NPDR) and more advanced 
(severe NPDR and PDR) DR. The peripapillary circular 
thickness (D scan) had the ROC curve with the highest 
AUC value (0.756, p<0.001). The sensitivity and specific-
ity for a cutoff point of 203 µm were 71.1% and 64.2%, 
respectively. We suspected an eye of being in an advanced 
stage DR when the D scan value of the eye was greater Korean J Ophthalmol Vol.24, No.1, 2010
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Fig. 3. Comparison of baseline retinal thickness of panretinal photo-
coagulation (PRP) (26 eyes) and No-PRP group (45 eyes). The two 
groups consisted of diabetic eyes with severe non-proliferative dia-
betic retinopathy or proliferative diabetic retinopathy. Subsequent 
PRP was conducted for the PRP group within the 6 month follow-up 
period after baseline optic coherence tomography measurements 
due to disease progression. Asterisks indicate significant differ-
ences between the two groups: 
*p<0.05.
H=horizontal in macula; V=vertical in macula; S=superior to optic
disc; I=inferior to optic disc; N=nasal to optic disc; D=circular con-
centric to optic disc; CMT=central macular thickness at fovea pit.
than the cutoff point. Shifting this cutoff point to 210 µm 
increased the specificity to 75.5%, but reduced the sensi-
tivity to 61.8%.
Among the 129 diabetics with DR, with a mean fol-
low-up of 16.3±4.7 months (range, 6 to 28 months), 27 
patients (20.9%) had been treated by PRP within 6 months 
of the baseline OCT scan. Zero percent showed mild 
NPDR, 2.6% moderate NPDR, 26% severe NPDR, and 
61.9% PDR. We compared the baseline retinal thicknesses 
between the PRP group and No-PRP group. To prevent 
bias from the mild and moderate NPDR group that con-
tained a relatively low proportion of treated patients and 
relatively thin retinal thicknesses, the comparison included 
only 71 patients with severe NPDR or PDR. The baseline 
retinal thicknesses of the PRP group (26 eyes) tended to 
be greater than that of the No-PRP group (45 eyes) in all 
OCT scans, but only the D scans were significantly differ-
ent (independent t test, p =0.041) (Fig. 3). Table 4 shows 
the AUC values for each retinal thickness measurement for 
discrimination between the PRP and No-PRP group. The 
D scan produced the ROC curve with the highest AUC 
value (0.623, p=0.047) for discrimination between the two 
groups. Sensitivity and specificity at a cutoff point of 233 
µm were 42.3% and 84.4%, respectively. The relative risk 
of the D scan≥233 µm for PRP was 1.941 (95% CI, 1.066 
to 3.533). 
Discussion
In this study, the thicknesses of seven OCT scans in the 
macular and peripapillary retina were significantly greater 
in DR eyes than in normal eyes. Also detected were sig-
nificant differences in retinal thickness in each of the 
scans when all DR groups were compared. The retinal 
thickness tended to be greater in more advanced stages of 
DR than in the early stages. The CMT measurements had 
the largest standard deviation among all OCT parameters 
through all stages of DR, and this variability of CMT miti-
gated the statistical significance of the results. 
A key factor in the pathological process of diabetic retinal 
edema is the increased permeability of the BRB [17].  As 
evidenced by fluorescein angiography of diffuse macular 
edema, micro-vascular obstruction and the resultant ische-
mia induce derangements in the integrity of the inner BRB 
[18]. The breakdown of the inner BRB results in accumu-
lation of fluid within the extracellular space. Damage to 
the outer BRB at the level of the retinal pigment epi-
thelium has also been suggested as a mechanism for the 
development of diffuse edema [19]. If the fluid resulting 
from inner or outer BRB damage is in excess of the 
amount that can be removed by the active pump mechanism, 
intraretinal and subretinal fluid continues to accumulate. 
Thus, if we quantify the increased retinal thickness resulting 
from pathological edema, we may determine the extent of 
altered BRB function in cases of DR [20]. Our finding that 
more advanced DR was associated with increased peripapil-
lary retinal thickness is consistent with this assumption.
The current statistical methodology indicates that our 
retinal thickness measurement with OCT can be employed 
as a diagnostic and prognostic factor in cases of DR [21]. 
Using ROC analysis, we evaluated the effectiveness of the 
measurement for DR staging, and PRP prediction within 6 
months. AUCs between 0.50 and 0.70 were considered to 
represent low diagnostic accuracy, whereas AUC values in 
excess of 0.90 were suggestive of high accuracy [15]. Although 
other OCT parameters demonstrated comparably significant 
results, peripapillary circular thickness had the ROC curve 
with the highest diagnostic power (AUC, 0.756) with re-
gard to discrimination between early (mild and moderate 
NPDR) and advanced (severe NPDR and PDR) stages of 
DR. Our results also indicate that peripapillary circular 
thickness in the PRP group was significantly greater than 
that of the No-PRP group upon baseline OCT, and that 
peripapillary circular thickness had the ROC curve with 
the highest degree of diagnostic power (AUC, 0.623) for 
discrimination between the two groups. Using a cut-off val-
ue of 233 µm for the peripapillary circular thickness, severe 
NPDR or PDR patients with peripapillary circular thick-
ness ≥233 µm upon baseline OCT can be considered to be 
1.94 times more likely to require PRP within 6 months 
than patients with peripapillary circular thickness of <233 
µm. This finding suggests that peripapillary retinal thickness 
may have prognostic value for identifying diabetic eyes at 
higher risk for imminent progression. 
The principal question is why peripapillary circular 
*P=0.041HY Cho, et al. Diabetic Retinopathy and PeripapillaryThickness
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thickness shows greater diagnostic power than other OCT 
parameters. We suggest several potential explanations: First, 
in the peripapillary area, the thickness of the nerve fiber 
layer is greatest, and the retinal inner layer is responsible 
for the largest proportion of retinal thickness. The break-
down of the inner BRB provides the most apparent cause 
for the thickening of the retina in this area. Secondly, the 
thickening of the peripapillary retina is less variable than 
macular thickening, which results principally from edema 
of the outer plexiform layer. The erratic changes in macular 
thickness may exert a considerable degree of influence on 
the significance of statistical analyses. The smaller standard 
deviation of retinal thickness in the peripapillary area, 
when compared with that in the macular area, reinforces 
this assumption.
This study has several limitations. We determined the 
retinal thicknesses using two-dimensional cross-sectional 
images with the Line mode. This procedure ignores possible 
information from the Radial Lines Mode of the acquisition 
software that utilizes a color-coded retinal thickness map 
with sectored topographic images [22]. Unfortunately, the 
topographic scanning on the Stratus OCT was unavailable 
in the peripapillary region. Again, because we could not 
obtain the average thickness directly in the Line mode of 
acquisition, we re-processed the original scan images, using 
an image analysis program, representing a potential source 
of error. Moreover, there is no normative database regarding 
the peripapillary retinal thickness in the general population. 
We used an arbitrarily selected cut-off value to evaluate 
predictive accuracy, and this is also a potential shortcoming 
of our study. Furthermore, the significant inter-individual 
variability of retinal thickness might limit the clinical ap-
plication of our findings. As age is one of the possible fac-
tors that influences inter-individual variability, we conducted 
age-matching between the diabetic and normal subjects, 
but matching was not fully accomplished in all sub-groups 
of DR. 
To the best of our knowledge, there have been no previous 
studies that analyzed OCT encompassing peripapillary retinal 
thickness in cases of DR. Prior studies have generally 
been limited to retinal thickness at the macula [23-25]. In 
this study, we have confirmed that the measurement of 
peripapillary retinal thickening determines the severity of 
DR more effectively than evaluations of macular thickness.
Although AUC appears to have modest diagnostic accuracy, 
the measurement of peripapillary retinal thickness utilizing 
OCT is very simple and noninvasive. When combined 
with other factors in a predictive model, the measurement 
of peripapillary retinal thickness is expected to be useful 
for DR screening. The next generation of OCT may allow 
for the accurate assessment of the peripapillary retinal volume 
or the thickness of specific retinal layers with even shorter 
scanning time. Future studies should develop a more sensitive 
and specific protocol to determine the severity of DR. 
In conclusion, peripapillary retinal thickness may prove 
to be a useful diagnostic tool for determining the severity 
of diabetic changes. Screening for this indicator in diabetic 
patients may also be important for quantifying the need for 
imminent treatment, thereby preventing disease progression.
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